We previously reported that R7D447, a 2954-base-pair (bp) laboratory-generated Moloney murine sarcoma virus, induced subcutaneous tumors in about 14% of infected mice but did not induce brain lesions. We now report that R7D447K, a spontaneous mutant of R7D447, induced brain lesions as well as subcutaneous tumors in all injected mice. The genomes of the two viruses dier in a single base pair: the deduced Glu 62 of the Mos residue of the R7D447 Gag-tMos protein is changed to Lys 62 . More R7D447 than R7D447K focus-forming units were detected in both NIH3T3 and mouse cerebral vascular endothelial (MCVE) cells. However, R7D447K transformed NIH3T3 and MCVE cells more acutely than did R7D447. A distinctive feature that distinguished the morphologic transformation of R7D447-and R7D447K-infected MCVE cells is the markedly prolonged spindleshaped phase exhibited by R7D447-infected MCVE cells. In addition, R7D447K was more ecient in inducing the phosphorylation of ERK1/2 than R7D447 in both MCVE and NIH3T3 cells. Moreover morphologic transformation was inhibited, and levels of phosphorylated ERK1/2 were reduced when R7D447-or R7D447K-infected NIH3T3 or MCVE cells were grown in the presence of the MEK1/2-speci®c inhibitor PD98095. Thus, we have identi®ed a key residue in the Gag-tMos protein that profoundly aects activation of the Mos/ MEK/ERK pathway, virus and cell replication, morphologic transformation in vitro and pathogenicity in vivo. Oncogene (2001) 20, 692 ± 703.
Introduction
All known Moloney murine sarcoma virus (MoMuSV) strains induce subcutaneous sarcomas in mice (Berman and Allison, 1969; Chirigos et al., 1968; Gazdar et al., 1972; Perk and Moloney, 1966; Simons and McCully, 1970; Stanton et al., 1968; Stoica et al., 1990; Yuen et al., 1991; Yuen and Kwak, 1997) .
Plasma-passaged sarcoma virus (SV-PP), a variant of MoMuSV obtained by animal passage, and its subclone, myeloproliferative sarcoma virus (MPSV), induce not only subcutaneous sarcomas but also myeloproliferation in mice (Chirigos et al., 1968; Le Bousse-Kerdiles et al., 1980; Ostertag et al., 1980; Stoica et al., 1990; Yuen et al., 1991) . R7, a spontaneously generated MoMuSV124 deletion mutant, and the laboratory-generated SV7d1 and SVM1 induce not only subcutaneous sarcomas but also brain angioendotheliomas and brain hemorrhage (collectively referred to as brain lesions) in all infected mice Kwak, 1997, 1998) . Two other poorly characterized MoMuSVs were also reported to induce brain lesions in 53% of rats injected intravenously (Hayashi et al., 1988) and 90% of rats injected intracerebrally (Ribacchi and Giraldo, 1966) . Transgenic mice carrying the c-mos or v-mos gene¯anked by MSV m1 long terminal repeats (LTRs) have been reported to develop behavioral abnormalities and neurologic symptoms, though only the v-mos transgenic mice develop paralysis. Interestingly, neither the c-mos nor the v-mos transgene induces sarcomas (Propst et al., 1990 (Propst et al., , 1992 .
In this light, we became interested in determining the basis for the brain lesion-inducing ability of these Mosexpressing viruses. From sequence analysis of the R7 genome, we learned that the R7 genome diers structurally from the MoMuSV124 genome in several important ways including the generation of a p15-p30-tmos open reading frame (ORF) that results in the expression of a p15-p30-tMos fusion protein that is likely myristylated Yuen and Kwak, 1997) . Moreover, sequential deletion of the gag sequence of the R7 gag-tmos ORF gradually abolishes the brain lesion-inducing ability of R7, indicating that the Gag residues of the Gag-tMos protein contribute to the brain lesion-inducing ability of R7 . Among the gag deletion mutants we studied, R7D447 failed to induce brain lesions. In the R7D447 genome, the entire gag sequence was deleted except for the ®rst 15 bp of the p15 coding sequence. In addition, we recently isolated a spontaneous mutant of R7D447 that induced brain lesions in all injected mice. Thus, R7D447 and its brain lesion-inducing mutant provided a means to further examine the genetic element(s) critical for brain lesion induction. In the present study, we demonstrated that the genomes of R7D447 and its mutant dier only in a single point mutation that changes the deduced Glu 62 residue of the Mos residues of the R7D447 Gag-tMos protein to a Lys. This ®nding emphasizes the profound eect a single point mutation had on the activity of a Mos oncoprotein and on the disease-inducing potential of the virus.
Results

Pathology induced by R7D447 and R7D447 var
Previously, we reported that only one of 27 mice injected with 1 ± 2610 5 R7D447 focus-forming units (FFUs), as determined by the NIH3T3 assay described in Materials and methods, became moribund 45 days post-infection (d.p.i.); the remainder remained healthy 60 d.p.i. . An additional 12 mice, each injected with 1. var -infected mice also developed brain lesions as well as subcutaneous tumors at the injection sites. These subcutaneous tumors, which had variable thicknesses and maximal lengths ranging from 6 ± 30 mm, were much larger than those induced by R7D447. The R7D447 var -induced brain lesions appeared as dark red spots up to 3 mm in diameter and could be observed with the naked eye ( Figure 1a ). They were found in the cortex, cerebellum, and occasionally the brain stem and olfactory lobes. Examination of whole brains of R7D447 var -infected mice showed that six (29%) of 21 infected brains had over 15 lesions, eight (38%) had 5 ± 15 lesions, and seven (33%) had fewer than ®ve lesions. Microscopic examination of brain sections revealed that the R7D447 var -induced brain lesions were hemorrhages and angioendotheliomas (Figure 1b,c) . In cross sections, the angioendotheliomas consisted of small cell clusters, scattered and abnormally enlarged cells, vessels lined by normal to abnormally enlarged endothelial cells (ECs), and extensive hemorrhage (Figure 1d ). Bandeiraea simplicifolia-1 (BS-1), a lectin that binds speci®cally to ECs (Alroy et al., 1987) , was shown to stain not only the cell membrane of ECs lining vessels but also tumor cells, and especially vacuolated tumor cells, of brain angioendotheliomas (Figure 1e ), thus rearming that the brain tumor cells belonged to the EC lineage.
Microscopically, all R7D447 var -induced subcutaneous tumors consisted of tightly packed tumor cells ®lling the subcutaneous space and in®ltrating and degrading the underlying muscle layer. These tumor cells consisted of ®broblasts interspersed among small cell clusters and/or polynucleated large cells that were usually vacuolated (Figure 1f) . Eccentric, mononucleated, abnormally enlarged cells were also observed. Red blood cells and in¯ammatory cells had in®ltrated the tumor. Besides normal blood vessels, dilated blood vessels lined with normal to abnormally enlarged cells with eccentric nuclei were seen occasionally. BS-1 stained the cell membranes of normal and enlarged cells lining the vessels and nonvacuolated large cells and also stained the cytoplasm and sometimes the nuclei of the vacuolated mono-or polynucleated large cells (data not shown). These observations indicate that the abnormally enlarged cells were of EC origin.
Microscopic examination of the plaque-like subcutaneous tumors from all ®ve R7D447-infected mice revealed tightly packed spindle-shaped ®broblasts in®ltrated by in¯ammatory cells (Figure 1g ). In contrast to R7D447 var -induced subcutaneous tumors, R7D447-induced subcutaneous tumors rarely contained mononucleated large cells with eccentric nuclei, polynucleated cells, small cell clusters (Figure 1g , inset), or dilated vessels lined by abnormally enlarged ECs.
The pathological data presented above clearly indicated that R7D447 var was more virulent than R7D447.
Viral dosage
We have previously shown that dosage does aect the incidence of brain lesions induced . Therefore, it may be argued that the reduced incidence of subcutaneous tumors and the absence of brain lesions induced by R7D447 could be due to the slightly lower number of FFUs injected. However, we have noticed that when highly diluted R7D447-containing supernatants were assayed in NIH3T3 cells, most of the foci induced consisted of a few weakly refractile cells barely distinguishable from the surrounding cells. Therefore, we could have underestimated the number of FFUs because of the reduced transforming activity of R7D447. To determine if this was the case, we indirectly compared the number of particles in the supernatant stocks of R7D447 and R7D447 var that had been previously injected. On the basis of the NIH3T3 assay, 10 6 FFUs from each stock of supernatant were pelleted and their virion RNA (vRNA) extracted. An equal volume of vRNA was used as template to amplify a 199-bp fragment spanning the 5' noncoding sequence and the N-terminus of the gag-tmos ORF by RT ± PCR using primers ms51/ms32 as described in Materials and methods. As shown in Figure 2 , we obtained more R7D447-than R7D447 var -ampli®ed gagtmos product. Thus, contrary to the ®ndings of the NIH3T3 assay, there were, in fact, more particles in the R7D447-than in the R7D447 var -containing supernatants. We further showed that when the number of FFUs was serially halved, the amount of RT ± PCRampli®ed gag-tmos product was also proportionately reduced (Figure 2) , thus validating the conclusion that there were more R7D447 particles injected than indicated by the NIH3T3 assay. Therefore, the number of particles injected could not have accounted for the inability of R7D447 to induce brain lesions or the signi®cantly lower incidence of subcutaneous tumors induced by R7D447.
R7D447 and R7D447 var assayed in MCVE cells
The results obtained from the RT ± PCR experiments demonstrated that there were R7D447 particles in the inoculum not detected by the NIH3T3 focus-forming assay. This suggests that the NIH3T3 focus-forming assay may not be sensitive enough to detect a single R7D447 particle. Since R7D447 var also induced brain angioendotheliomas, and cultured mouse cerebral vascular endothelial (MCVE) cells were available to us, we compared the number of FFUs detected when stocks of R7D447 and R7D447 var were simultaneously assayed in NIH3T3 and MCVE cells. We showed that when 12 and 13 supernatants containing R7D447 or R7D447 var , respectively, were assayed, 2 ± 8-fold more R7D447 FFUs (average 4.8+s.d. 1.8) were detected using MCVE than NIH3T3 cells (Figure 3a) . In contrast, 2 ± 11-fold more FFUs (average 4.8+s.d. H&E, bar=100 mm. Inset, H&E, bar=20 mm. (g) Section of a subcutaneous tumor from an R7D447-infected mouse showing tightly packed ®broblasts and scattered normal vessels (arrow). H&E, bar=100 mm. Inset shows an infrequently observed small cell cluster similar to those found in R7D447 var -induced subcutaneous tumors. H&E, bar=20 mm 3.8) were detected when R7D447 var was assayed in NIH3T3 than in MCVE cells ( Figure 3b ). Thus, MCVE cells appeared to be more sensitive in detecting R7D447 than NIH3T3 cells. In contrast, NIH3T3 cells appeared to be more sensitive in detecting R7D447 var than MCVE cells. These ®ndings substantiated the previous ®nding by the indirect particle assay that the injected supernatant contained more R7D447 particles than detected by the NIH3T3 focus-forming assay. Therefore, the amount of R7D447 injected was not responsible for the marked decrease in the incidence of subcutaneous tumors or the absence of brain lesions induced by R7D447. In addition, in light of the dierences in the number of FFUs obtained using NIH3T3 and MCVE as indicator cells, all R7D447 stocks were titered using MCVE cells whereas all R7D447 var stocks were titered using NIH3T3 cells in subsequent experiments.
Replication efficiency of R7D447 and R7D447 var
We next examined the replication eciency of R7D447 and R7D447 var to determine if it could account for the dierence in pathogenicity manifested. We have already shown that R7 induces brain lesions in all mice injected within 48 h after birth (Yuen and Kwak, 1998) but fails to do so in mice injected 5 days after birth (Yuen, unpublished data) . This ®nding suggests that brain-vessel ECs may only be susceptible to R7 transformation during the ®rst few days after birth. The gradual loss of susceptibility to neurodegeneration caused by replication-competent mouse retroviruses as the neonate ages has also been reported (GonzalesScarano et al., 1995; Wong, 1990) . Thus, an increase in the rate of virus replication is advantageous for brain pathogenicity.
To compare the replication eciency of R7D447 and R7D447 var , we infected NIH3T3 and MCVE cells with R7D447 or R7D447
var at a multiplicity of infection (moi) of 3. When the cells became subcon¯uent, the medium of each culture was replaced with 5 ml of fresh medium. Twenty-four hours later, the supernatants were harvested, and the number of FFUs released was determined using both the NIH3T3 and MCVE focusforming assays. As shown in Figure 4 , the results obtained con®rmed that the MCVE assay was more sensitive in detecting R7D447 FFUs whereas the NIH3T3 assay was more sensitive in detecting R7D447 var FFUs. Of greater interest was the ®nding that NIH3T3 cells produced more R7D447 and R7D447 var FFUs than did MCVE cells. R7D447-infected NIH3T3 cells produced twofold and about sixfold more FFUs than R7D447-infected MCVE cells as determined by the NIH3T3 and MCVE assay, respectively ( Figure 4a ). R7D447 var -infected NIH3T3 cells produced about 15-and sevenfold more FFUs 6 FFUs was ampli®ed by RT ± PCR as described in Materials and methods. Lanes 1 ± 3, RT ± PCR products ampli®ed from vRNA of three dierent R7D447 inocula; lanes 4 ± 6, RT ± PCR products ampli®ed from vRNA of three dierent R7D447 var inocula. (b) The amounts of RT ± PCR products ampli®ed from vRNA extracted from virions pelleted from twofold serially diluted R7D447 or R7D447 var supernatants were compared. Lanes 1 ± 4, RT ± PCR products ampli®ed from R7D447 vRNA; lanes 5 and 6, RT ± PCR products ampli®ed from R7D447 var vRNA Figure 3 Comparison of the number of FFUs detected by the NIH3T3 and MCVE cell focus-forming assays. The assays were performed as described in Materials and methods. The results obtained are presented as an average of the ratios of (a) the number of FFUs obtained by the MCVE focus-forming assay to the number of FFUs obtained by the NIH3T3 focus-forming assay or (b) the average of the reciprocal ratios. Error bars=standard deviation, n=number of supernatants assayed than R7D447 var -infected MCVE cells as determined by the NIH3T3 and MCVE assays, respectively ( Figure  4b ). When we compared the numbers of FFUs produced by R7D447-and R7D447 var -infected NIH3T3 cells using the higher titers obtained for each virus (i.e., the R7D447 titer obtained by the MCVE assay and the R7D447 var titer obtained by the NIH3T3 assay), we showed that R7D447 produced about threefold more FFUs than did R7D447
var . Likewise, when we compared the number of FFUs produced by R7D447-and R7D447 var -infected MCVE cells using the higher titers obtained for each virus, we showed that R7D447 produced about sevenfold more FFUs than did R7D447 var . Thus, R7D447 replicated better than did R7D447 var in both NIH3T3 and MCVE cells. Therefore, it appears unlikely that replication eciency was a causative factor in the low pathogenicity manifested by R7D447.
Genomes of R7D447 and R7D447 var As the above results clearly showed, the reduced virulence of R7D447 cannot simply be attributed to fewer virus particles injected or to reduced replication eciency. Therefore, it appears likely that the R7D447 genome had mutated in a region that in¯uenced its disease-inducing potential without aecting its replication. To con®rm this, we compared the genome sequence of R7D447 and R7D447 var . We have previously sequenced the R7D447 genome . R7D447 is a deletion mutant of R7. Dierences between the R7D447 and R7 genomes (Yuen and Kwak, 1997 ) (GeneBank Accession No. AF011892) are illustrated in Figure 5a ,b. Compared with R7, R7D447 had a 447-bp deletion extending from bp 1141 to 1587 (inclusive). The R7D447 deletion encompassed 153 bp of p15, all 263 bp of p30, the 6-bp R7 gag-tmos junction sequence, the 7-bp insert, and the ®rst 18 bp of the R7 tmos gene (Yuen and Kwak, 1997) . Sequence analysis of the R7D447 var genome showed it to be identical to the R7D447 genome, except for a G ± A mutation at bp 1301 of the R7D447 genome ( Figure  5c ). This mutation changed a Mos residue at position 62 of the R7D447 Gag-tMos protein from glutamic acid (Glu, E) to lysine (Lys, K) (Figure 5d ). Glu 62 corresponds to Glu 128 of the MoMuSV124 Env-Mos protein. Since the R7D447 var sequence diered from the R7D447 sequence only in the Glu(E)-to-Lys(K) mutation, we renamed R7D447 var as R7D447K.
R7D447-or R7D447K-induced morphological changes of NIH3T3 and MCVE cells
The ®nding that a point mutation in the R7D447 mos ORF is the only dierence between the R7D447 and R7D447K genomes indicated that the marked dierence in the pathology induced by R7D447 and R7D447K must be due to the activity of their unique Gag-tMos proteins. To determine if the Gag-tMos proteins of R7D447 and R7D447K dier in transforming activity, we compared the morphological changes in NIH3T3 and MCVE cells after 10 5 cells of each cell type were infected with 10 ± 100 FFUs of R7D447 or R7D447K. We examined the eects of R7D447 and R7D447K on these cell types because (a) R7D447 and R7D447K both induce subcutaneous ®brosarcomas with an angiomatous component, albeit poorly in the case of R7D447 infection, and (b) R7D447K also induces brain angioendotheliomas.
NIH3T3 cells infected with R7D447 or R7D447K basically underwent a series of morphological changes from weakly refractile polygons to refractile spindle- Figure 4 The number of FFUs produced by R7D447 and R7D447 var in NIH3T3 and MCVE cells. NIH3T3 and MCVE cells were infected with R7D447 (a) or R7D447 var (b) at an moi of 3. When the cells were subcon¯uent, the medium was replaced with 5 ml fresh medium. Twenty-four hours later, each supernatant was harvested and ®ltered through a 0.45-mm membrane ®lter. The total number of cells in each plate was also counted. The number of focus-forming units (FFUs) in the supernatants was simultaneously determined as previously described for the NIH3T3 focus-forming assay (Figure 6c ). As the number of transformed cells increased, the amount of cell debris also increased forming a¯u over the focus ( Figure  6d ). The number of plump, oval-to-round refractile Figure 5 Schematic illustrations of the R7 (a) and R7D447 (b) genomes and the deduced amino acid sequence of the N-terminus of the R7D447 Gag-tMos protein (c). The R7 genome as illustrated in (a) has been previously published . Except for 447 in (b), which denotes the number of bp deleted from the R7 genome, the numbers shown in (a) and (b) denote positions of base pairs at the beginning or end of a genomic fragment. H, HindIII; P, PstI. (c) The deduced, ®rst 80 residues of the R7D447 Gag-tMos protein. The ®rst ®ve residues are derived from the ®rst ®ve residues of the N-terminal MoMuLV p15 Gag protein. The remaining residues are numbered according to the MoMuSV124 Env-Mos sequence (Van Beveren et al., 1981) . Residues 6 and 80 of the R7D447 Gag-tMos correspond to residues 72 and 145 of the MoMuSV124 Env-Mos sequence, respectively. The residues conserved among all serine/threonine kinases are in bold letters; the residues previously shown to aect Mos function (Freeman et al., 1992; Hanks et al., 1988; Hannink and Donoghue, 1985; Puls et al., 1995; Schmidt et al., 1988; van der Hoorn and Firzla, 1984) are circled; the Glu residue mutated in R7D447K is enclosed in a hexagon. The putative secondary structure is based on the modeling of Robertson and Donaghue (1996) (Figure 6e ,f). The foci also had a few scattered, more refractile, oval-to-round cells. These foci of transformed cells, although weakly refractile, were well demarcated from the surrounding cells. For 7 ± 9 days after the foci appeared, the number of cells in each focus continued to increase with little change in cell morphology. Then, interestingly, cells in the center of each focus became darker. This darkening eventually spread to all cells in the focus over 1 ± 2 days. Then, almost synchronously, the spindle-shaped cells at the center of the focus became round for about 24 h ( Figure 6g ) and then degraded (Figure 6h) . Cells on the periphery of the focus (most likely more recently infected cells) followed the same cycle of darkening, rounding, and dying. This cycle was repeated until eventually all that was left of the focus was vacuoles surrounded by cell debris. R7D447-and R7D447K-infected MCVE cells were not observed beyond 21 d.p.i.
Thus, it appears that R7D447 and R7D447K infection diers in the following ways: (a) R7D447K induced the sequential morphological changes in both NIH3T3 and MCVE cells faster than did R7D447; (b) R7D447K also induced refractility of the infected cells more intensely than did R7D447; (c) R7D447 and R7D447K infection of MCVE cells diered in the progression of morphological transformation, most noticeably in the duration of the spindle-shaped phase. R7D447K-infected MCVE cells progressed rapidly, probably within 1 ± 2 days, from spindle-shaped to round, whereas the same process took 7 ± 9 days in R7D447-infected MCVE cells. Lastly, (d) although R7D447 or R7D447K infection induced cell death in NIH3T3 cells, the rate of cell death was slower than the replacement rate of infected cells, thus allowing the transformed cells to accumulate. In contrast, in R7D447-and R7D447K-infected MCVE cells, when recruitment of uninfected cells was limiting, the rate of cell death was faster than the rate of replication of infected cells, so transformed cells eventually disappeared.
Replication of R7D447-or R7D447K-infected MCVE and NIH3T3 cells
To help explain the observed dierences in morphology induced by R7D447 and R7D447K, we compared the number of live R7D447-or R7D447K-infected NIH3T3 and MCVE cells as a function of time using the Trypan blue exclusion assay as described in Materials and methods. NIH3T3 and MCVE cells were infected with R7D447 or R7D447K at an moi of 5. The growth curves demonstrated that, during the ®rst 3 d.p.i., R7D447-and R7D447K-infected NIH3T3 and MCVE cells proliferated at the same rate as uninfected cells (Figure 7a) . After 4 d.p.i., the growth curves diverged. By 7 ± 8 d.p.i., the numbers of viable uninfected NIH3T3 cells were signi®cantly greater (P50.05) than those of R7D447-and R7D447K-infected NIH3T3 cells, and the numbers of viable R7D447-infected NIH3T3 cells were signi®cantly greater (P50.05) than those of R7D447K-infected NIH3T3 cells. Interestingly, between 4 and 8 d.p.i., the numbers of viable R7D447K-infected MCVE cells were not signi®cantly dierent from those of uninfected MCVE cells. In (Figure 7b ). When NIH3T3 and MCVE cells were infected with R7D447 and R7D447K at an moi of 2.5, the resulting growth curves were not signi®cantly dierent from those obtained when the cells were infected at an moi of 5 (data not shown).
Differing ability of R7D447 and R7D447K to phosphorylate mitogen-activated protein kinase (MAPK)
It has been previously shown that c-Mos and v-Mos activate MEK (Mansour et al., 1994; Pham et al., 1995; Topol and Blair, 1995) and that v-Mos activates p44ERK1 and p42ERK2 (ERK1/2) (Topol and Blair, 1995) . In addition, p45MEK1 and p46MEK2 (MEK1/ 2) activate ERK1/2 (Cobb, 1999) . Taken together, these reports indicate that Mos activates ERK1/2 via MEK1/2. Therefore, we investigated whether the R7D447 and R7D447K Gag-tMos proteins dierentially activate ERK1/2 in NIH3T3 and MCVE cells. We showed by Western blot analysis that more GagtMos was detected in R7D447-than in R7D447K-infected NIH3T3 and MCVE cells (Figure 8a,d) . We also demonstrated that less phosphorylated ERK1/2 was detected in R7D447-than in R7D447K-infected NIH3T3 cells (Figure 8b) , and similar amounts of phosphorylated ERK1/2 were detected in R7D447-and R7D447K-infected MCVE cells (Figure 8e ). When the amounts of phosphorylated ERK1/2 were normalized to the amounts of v-Mos detected, we demonstrated that R7D447K Gag-tMos induced dramatically more phosphorylated ERK1/2 than did R7D447 Gag-tMos in both NIH3T3 and MCVE cells (data not shown). In addition, the amount of phosphorylated ERK1/2 induced per unit R7D447K Gag-tMos between 2 and 5 d.p.i. in MCVE cells was 4 ± 7-fold lower than in NIH3T3 cells (data not shown).
PD98059-induced reductions of transformation and ERK1/2 phosphorylation in R7D447-and R7D447K-infected NIH3T3 and MCVE cells
Since MEK1/2 are the known upstream activators of ERK1/2 (Cobb, 1999) , we investigated whether phosphorylation of ERK1/2 in R7D447K-or R7D447-infected NIH3T3 and MCVE cells is mediated by MEK1/2 activation. To do so, we examined the eects of the MEK1/2 inhibitor PD98059 (Dudley et al., 1995) (Calbiochem, La Jolla, CA, USA) on R7D447-and R7D447K-induced transformation and ERK1/2 phosphorylation in NIH3T3 and MCVE cells.
MCVE cells were infected with R7D447 or R7D447K at an moi of 5 in the presence or absence of 25 mM PD98059. PD98059 had no eect on uninfected MCVE cells but dramatically reduced the transformation of R7D447-infected MCVE cells (data not shown). PD98059-treated R7D447K-infected MCVE cells were less transformed than their untreated counterparts but still exhibited some refractile spindle-shaped and round cells. Similar results were observed when NIH3T3 cells chronically infected with R7D447 or R7D447K were treated with 25 mM PD98059.
We next determined whether PD98059 had in fact blocked the phosphorylation of ERK1/2 induced by R7D447 and R7D447K Gag-tMos. NIH3T3 and MCVE cells were infected with R7D447 or R7D447K at an moi of 5 in the presence or absence of 25 mM PD98059. The addition of PD98059 dramatically reduced the amounts of ERK1/2 phosphorylated in both R7D447-and R7D447K-infected NIH3T3 and MCVE cells (data not shown). Thus, we have demonstrated that MEK1/2 activate ERK1/2 and that activation of MEK1/2 is required for morphological transformation.
Discussion
We have generated R7D447, a 2954-bp MoMuSV composed of a gag-tmos ORF¯anked by LTRs each containing three direct repeats and noncoding 5' and 3' sequences (Figure 5b) , and shown that it induced , 1996) . Interestingly, the homologous residue in v-mos m1 (Brow et al., 1984) and v-mos MPSV (Stacey et al., 1984) is also a Lys, and Brow et al. (1984) suggested that this residue may play a role in the folding of the protein. Our ®ndings indicate that the single Glu
62
-to-Lys 62 mutation alone is sucient to enable the mutant virus, R7D447K, to induce brain lesions and enhance its ability to induce subcutaneous tumors in all injected mice. Interestingly, the corresponding residues of the R7 Gag-tMos (Yuen and Kwak, 1997) and SV7d1 Env-Mos protein at positions 211 and 218, respectively, are also Glu, whereas residue 218 of the SVM1 Env-Mos protein is Lys . Nevertheless, these viruses induce brain lesions and subcutaneous tumors in all injected mice. Thus, the presence of a Glu residue at this position does not always prevent the induction of brain lesions or reduce the incidence of subcutaneous tumors. Furthermore, the MoMuSV124 EnvMos, the R7 Gag-tMos, and the R7D447K Gag-tMos proteins dier in their N-terminal sequences. This suggests that the type of residue present in position 62 of the R7D447 or R7D447K Gag-tMos proteins or the corresponding positions in the other Gag-tMos or EnvMos proteins and the eect this residue has on the function of the Mos protein may be in¯uenced by the sequence and length of their respective N-termini. This suggestion is consistent with our previous ®nding that sequential deletion of the internal Gag residues of the R7 Gag-tMos protein aects R7's ability to induce brain lesions (Yuen et al., 2000) .
The Glu
62
-to-Lys 62 mutation located in the aB helix between the ATP-binding domain and the aC helix (Figure 5d ) constitutes the ®rst report ascribing functional signi®cance to the sequence bridging the ATP-binding site and the aC helix. Previous studies have shown that Lys 121 , located in the Mos ATPbinding domain and conserved among all protein kinases (Hanks et al., 1988) , is required for MoMuSV124-mediated transformation of ®broblasts (Hannink and Donoghue, 1985) . It has also been shown that substitution of the Ser 136 residue located in the aC helix with Ala, inactivates the Xenopus Mos protein in the cytostatic factor assay (Freeman et al., 1992) . Furthermore, reversion of the Gly 145 residue located in the aC helix to Arg reportedly abolishes the constitutive kinase activity of the MoMuSV124 EnvMos protein (Puls et al., 1995) . The investigators cited above hypothesized that these mutations changed the conformation of the Mos proteins investigated, which in turn reduced or abolished the activity of the Mos proteins. It is conceivable that changing the Glu 62 residue to Lys 62 also altered the binding anity of the active site for ATP or a speci®c substrate. The former explanation is more likely in view of similar ®ndings by other investigators that disruption of the ATP-binding site is a mechanism of regulation of other protein kinases (De Bondt et al., 1993; Hu et al., 1994; Hubbard et al., 1994; Robinson et al., 1996) .
In the present study, we have also identi®ed important biological processes that are aected by changing the Glu 62 residue to a Lys
. These processes include (a) morphologic changes induced by R7D447 or R7D447K infection in NIH3T3 and MCVE cells; (b) replication of R7D447-and R7D447K-infected NIH3T3 and MCVE cells; (c) replication of R7D447 and R7D447K in NIH3T3 and MCVE cells; (d) activation of MEK1/2 and ERK1/2; and (e) induction of subcutaneous tumors and brain lesions. We have demonstrated that NIH3T3 and MCVE cells both respond dierentially to R7D447 and R7D447K infections, although both R7D447-or R7D447K- infected NIH3T3 and MCVE cells basically undergo the same series of morphological changes from polygons to refractile spindle-shaped cells to highly refractile round cells that die if acutely infected. In both cell types, R7D447K infection produces more intensely refractile plump, oval-to-round cells than does R7D447 infection. In addition, more cell death was observed microscopically in R7D447K-than in R7D447-infected cells. Interestingly, the Trypan blue exclusion assay also showed that, by 8 d.p.i., the number of R7D447-infected NIH3T3 and MCVE cells was 1.5 and 1.6 times greater than that of R7D447K-infected cells, respectively. These ®ndings indicated that R7D447-infected NIH3T3 and MCVE cells replicated better than R7D447K-infected cells and/or that more cell death occurred in R7D447K-than in R7D447-infected NIH3T3 and MCVE cells. The dierential replication of R7D447-and R7D447K-infected MCVE cells may be explained by the microscopic observation that R7D447-infected MCVE cells remained as spindleshaped cells longer than did R7D447K-infected MCVE cells. During this spindle-shaped phase, R7D447-infected MCVE cells continued to proliferate, generating heaped-up foci of tightly packed spindle-shaped cells. In contrast, R7D447K-infected MCVE cells progressed rapidly from spindle-shaped to round to dead. The explanation for the dierential replication of R7D447-and R7D447K-infected NIH3T3 cells remains to be investigated.
R7D447-infected MCVE cells produced about sevenfold more FFUs than did R7D447K-infected MCVE cells (Figure 4) . Likewise, R7D447-infected NIH3T3 cells produced about threefold more FFUs than did R7D447K-infected NIH3T3 cells (Figure 4) . The reduced replication of R7D447K in MCVE cells may be explained by the short time span available for R7D447K replication because the infected cells progressed rapidly from spindle-shaped to round to dead. In contrast, the occurrence of an extended proliferative spindle-shaped phase when R7D447 infected MCVE cells not only supported virus replication but also allowed more time for R7D447 to replicate, resulting in the production of more R7D447 particles. It is likely that the dierence in R7D447 and R7D447K replication in NIH3T3 cells may be similarly explained.
We have demonstrated that when NIH3T3 or MCVE cells were infected with R7D447 or R7D447K at the same moi, R7D447-infected cells unexpectedly produced considerably more Gag-tMos protein than did R7D447K-infected cells. This ®nding is consistent with the observation of Yew et al. (1991) that high levels of mos protein is correlated with inecient transforming activity. It is possible that cellular events resulting from acute transformation by R7D447K caused downregulation of de novo synthesis of the R7D447K Gag-tMos protein. Alternatively, MCVE cells, though more sensitive to R7D447 transformation than NIH3T3 cells (Figure 3) were still not sensitive enough to detect all R7D447 particles because of their reduced transforming activity. This underestimation would have resulted in cells being infected with a higher moi of R7D447 than R7D447K. This explanation appears unlikely because titration curves revealed one-hit kinetics of focus formation, indicating that the foci obtained were not caused by multiple infections (data not shown). Nevertheless, despite the greater amount of R7D447 Gag-tMos protein detection, we found considerably less phosphorylated ERK1/2 in R7D447-than in R7D447K-infected cells (Figure 8) . Therefore, the more acute transformation induced by R7D447K than in R7D447 in NIH3T3 and MCVE cells does not appear to correlate so much with the amount of v-Mos produced as with their eciency in inducing phosphorylation of ERK1/2. This implicates utilization of the MEK/ERK signaling cascade in R7D447-and R7D447K-induced NIH3T3 and MCVE cell transformation. This possibility was con®rmed by our demonstration that transformation of R7D447-or R7D447K-infected NIH3T3 and MCVE cells was inhibited by the MEK1/2-speci®c inhibitor PD98059. Therefore, our observations support those of other investigators that Mos activation of the MEK/ERK pathway is required for transformation of NIH3T3 cells (Okazaki and Sagata, 1995) and rat embryo ®broblasts (Topol and Blair, 1995) . Furthermore, the dierential activation of ERK1/2 in R7D447-and R7D447K-transformed NIH3T3 and MCVE cells correlates with the dierential induction of angiomatous subcutaneous tumors and brain angioendotheliomas in R7D447-and R7D447K-infected mice. This observation suggests that the Mos/MEK/ERK pathway is likely involved in the development of R7D447K-induced angiomatous subcutaneous tumors and brain lesions.
In summary, our ®ndings suggest that the Mos/ MEK/ERK pathway is likely involved in determining R7D447-or R7D447K-induced morphological changes, activation of the factors that determine the refractility displayed by the infected cells, replication or death of virus-infected NIH3T3 and MCVE cells, virus replication in NIH3T3 and MCVE cells, and pathogenicity. Identi®cation of downstream eectors of ERK that are involved in these processes would be helpful in understanding the mechanisms of each of these biological processes in vitro and the development of subcutaneous tumors and brain lesions in vivo.
Materials and methods
Cell culture
Mouse NIH3T3 ®broblasts were maintained as previously described (Yuen et al., 1991) . MCVE cells isolated from microvessels of BALB/c mouse brains were a gift from Dr JR Welsh (Texas A&M University, College Station, Texas, USA). A cell line with cobblestone morphology and contact inhibition, subcloned in our laboratory, was used in the present studies. MCVE cells were maintained in DMEM containing 10% fetal bovine serum, 100 mg/ml streptomycin, and 100 units/ml penicillin. 
